$CBUS
Cibus, Inc. Stock $cbus

$cbus Overview Financials Valuation SEC Filings Company Website

2018 Q2 Form 10-Q Financial Statement

#000119312518154661 Filed on May 07, 2018

Income Statement

Concept	2018 Q2	2018 Q1	2017 Q1
Revenue	$196.0K	$11.00K	$55.00K
YoY Change	-12.11%	-80.0%	-50.0%
Cost Of Revenue	$0.00	$0.00	$0.00
YoY Change			-100.0%
Gross Profit	$196.0K	$11.00K	$55.00K
YoY Change	-12.11%	-80.0%	450.0%
Gross Profit Margin	100.0%	100.0%	100.0%
Selling, General & Admin	$4.595M	$2.676M	$1.578M
YoY Change	128.61%	69.58%	31.5%
% of Gross Profit	2344.39%	24327.27%	2869.09%
Research & Development	$3.093M	$1.048M	$1.266M
YoY Change	112.87%	-17.22%	-7.59%
% of Gross Profit	1578.06%	9527.27%	2301.82%
Depreciation & Amortization	$215.0K	$156.0K	$133.0K
YoY Change	60.45%	17.29%	121.67%
% of Gross Profit	109.69%	1418.18%	241.82%
Operating Expenses	$7.688M	$4.307M	$2.844M
YoY Change	122.0%	51.44%	10.66%
Operating Profit	-$7.492M	-$4.296M	-$2.789M
YoY Change	131.23%	54.03%	8.95%
Interest Expense	-$72.00K	$235.0K	-$14.00K
YoY Change	140.0%	-1778.57%	40.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$7.576M	-$4.370M	-$2.832M
YoY Change	123.15%	54.31%	10.19%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$7.576M	-$4.370M	-$2.832M
YoY Change	123.15%	54.31%	10.19%
Net Earnings / Revenue	-3865.31%	-39727.27%	-5149.09%
Basic Earnings Per Share
Diluted Earnings Per Share	-$254.0K	-$156.9K	-$110.3K
COMMON SHARES
Basic Shares Outstanding	28.02M shares	28.06M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2018 Q2	2018 Q1	2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$105.6M	$50.70M	$3.000M
YoY Change	4124.0%	1590.0%
Cash & Equivalents	$105.6M	$50.70M	$3.007M
Short-Term Investments
Other Short-Term Assets	$1.500M	$2.100M	$600.0K
YoY Change	-44.44%	250.0%
Inventory
Prepaid Expenses
Receivables	$0.00	$0.00	$0.00
Other Receivables	$100.0K	$0.00	$0.00
Total Short-Term Assets	$107.2M	$52.83M	$3.700M
YoY Change	1913.85%	1327.84%
LONG-TERM ASSETS
Property, Plant & Equipment	$21.34M	$18.77M	$11.20M
YoY Change	88.26%	67.56%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$307.0K	$270.0K	$200.0K
YoY Change	9.64%	35.0%
Total Long-Term Assets	$21.64M	$19.04M	$11.40M
YoY Change	86.36%	66.99%
TOTAL ASSETS
Total Short-Term Assets	$107.2M	$52.83M	$3.700M
Total Long-Term Assets	$21.64M	$19.04M	$11.40M
Total Assets	$128.8M	$71.87M	$15.10M
YoY Change	660.71%	375.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.110M	$441.0K	$700.0K
YoY Change	-41.88%	-37.0%
Accrued Expenses	$1.959M	$1.256M	$1.000M
YoY Change	167.62%	25.6%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.042M	$2.972M	$4.000M
YoY Change	-43.35%	-25.7%
LONG-TERM LIABILITIES
Long-Term Debt	$17.40M	$14.80M	$0.00
YoY Change
Other Long-Term Liabilities	$100.0K	$300.0K	$600.0K
YoY Change	-80.0%	-50.0%
Total Long-Term Liabilities	$17.50M	$15.10M	$600.0K
YoY Change	3400.0%	2416.67%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.042M	$2.972M	$4.000M
Total Long-Term Liabilities	$17.50M	$15.10M	$600.0K
Total Liabilities	$22.60M	$18.01M	$4.700M
YoY Change	141.66%	283.13%
SHAREHOLDERS EQUITY
Retained Earnings	-$66.49M	-$58.92M
YoY Change	91.1%
Common Stock	$172.7M	$112.8M
YoY Change	307.59%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$106.2M	$53.86M	$10.40M
YoY Change
Total Liabilities & Shareholders Equity	$128.8M	$71.87M	$15.10M
YoY Change	660.71%	375.94%

Cashflow Statement

Concept	2018 Q2	2018 Q1	2017 Q1
OPERATING ACTIVITIES
Net Income	-$7.576M	-$4.370M	-$2.832M
YoY Change	123.15%	54.31%	10.19%
Depreciation, Depletion And Amortization	$215.0K	$156.0K	$133.0K
YoY Change	60.45%	17.29%	121.67%
Cash From Operating Activities	-$2.260M	-$6.565M	-$1.710M
YoY Change	-3.83%	283.92%	4.91%
INVESTING ACTIVITIES
Capital Expenditures	-$460.0K	$41.00K	$312.0K
YoY Change	53.33%	-86.86%	-104.6%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$460.0K	-$41.00K	-$310.0K
YoY Change	53.33%	-86.77%	-95.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	57.63M	645.0K	0.000
YoY Change	2555.76%
NET CHANGE
Cash From Operating Activities	-2.260M	-6.565M	-1.710M
Cash From Investing Activities	-460.0K	-41.00K	-310.0K
Cash From Financing Activities	57.63M	645.0K	0.000
Net Change In Cash	54.91M	-5.961M	-2.020M
YoY Change	-11539.58%	195.1%	-75.98%
FREE CASH FLOW
Cash From Operating Activities	-$2.260M	-$6.565M	-$1.710M
Capital Expenditures	-$460.0K	$41.00K	$312.0K
Free Cash Flow	-$1.800M	-$6.606M	-$2.022M
YoY Change	-12.2%	226.71%	-139.26%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	28020786	shares
CY2017Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2017Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	275000000	shares
CY2017Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2017Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2017Q3	clxt	Shares Authorized SharesAuthorized	325000000	shares
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3007000
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	49965000
CY2017Q3	clxt	Number Of Lease Extension Options NumberOfLeaseExtensionOptions	4	Options
CY2018Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1256000
CY2018Q1	us-gaap	Assets Current AssetsCurrent	52830000
CY2018Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	78000
CY2018Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0
CY2018Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1439000
CY2018Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	112775000
CY2018Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	441000
CY2018Q1	us-gaap	Assets Assets	71867000
CY2018Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	50703000
CY2018Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	275000000	shares
CY2018Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27954781	shares
CY2018Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27954781	shares
CY2018Q1	us-gaap	Common Stock Value CommonStockValue	3000
CY2018Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	43000
CY2018Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	278000
CY2018Q1	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	742000
CY2018Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	490000
CY2018Q1	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	47000
CY2018Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	3700000
CY2018Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	14500000
CY2018Q1	us-gaap	Liabilities Liabilities	18007000
CY2018Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	71867000
CY2018Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2972000
CY2018Q1	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	1000
CY2018Q1	us-gaap	Minimum Net Worth Required For Compliance MinimumNetWorthRequiredForCompliance	300000000
CY2018Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	270000
CY2018Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2018Q1	us-gaap	Preferred Stock Value PreferredStockValue
CY2018Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2080000
CY2018Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	18767000
CY2018Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	20206000
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-58918000
CY2018Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	9386000
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	14617000
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1125083	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	5.41
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3619506	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.60
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5026000
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	893000
CY2017Q4	us-gaap	Assets Current AssetsCurrent	57457000
CY2017Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	3000
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1283000
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	112021000
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	53860000
CY2018Q1	clxt	Capital Leases Obligations And Financing Leases Noncurrent CapitalLeasesObligationsAndFinancingLeasesNoncurrent	14757000
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1023000
CY2017Q4	us-gaap	Assets Assets	72167000
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56664000
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	275000000	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27718780	shares
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27718780	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	3000
CY2017Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	43000
CY2017Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	289000
CY2017Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	1350000
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	945000
CY2017Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	167000
CY2017Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	10100000
CY2017Q4	us-gaap	Liabilities Liabilities	14691000
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	72167000
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4254000
CY2017Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	4000
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	357000
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	626000
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14353000
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	15636000
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-54548000
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3883432	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.16
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	57476000
CY2017Q4	clxt	Capital Leases Obligations And Financing Leases Noncurrent CapitalLeasesObligationsAndFinancingLeasesNoncurrent	10148000
CY2017Q2	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	100	pure
CY2017Q3	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	3300000
CY2017Q3	us-gaap	Expense Related To Distribution Or Servicing And Underwriting Fees ExpenseRelatedToDistributionOrServicingAndUnderwritingFees	3100000
CY2017Q3	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	58000000
CY2017Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	2.45	pure
CY2017Q3	us-gaap	Lessee Finance Lease Renewal Term LesseeFinanceLeaseRenewalTerm	P5Y
CY2017Q3	us-gaap	Lessee Finance Lease Term Of Contract LesseeFinanceLeaseTermOfContract	P20Y
CY2017Q3	us-gaap	Sale Leaseback Transaction Net Proceeds Financing Activities SaleLeasebackTransactionNetProceedsFinancingActivities	7000000
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35	pure
CY2017	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0
CY2017	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	1600000
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y9M18D
CY2017Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2019000
CY2017Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	0
CY2017Q1	us-gaap	Costs And Expenses CostsAndExpenses	2844000
CY2017Q1	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	27000
CY2017Q1	us-gaap	Depreciation Depreciation	133000
CY2017Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.14
CY2017Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Net FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersNet	0
CY2017Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-29000
CY2017Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2832000
CY2017Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	45000
CY2017Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-89000
CY2017Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-110000
CY2017Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	418000
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	337000
CY2017Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	426000
CY2017Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-14000
CY2017Q1	us-gaap	Interest Paid InterestPaid	14000
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-312000
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-1707000
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-2832000
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2789000
CY2017Q1	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	65000
CY2017Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	312000
CY2017Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1266000
CY2017Q1	us-gaap	Sales Revenue Net SalesRevenueNet	55000
CY2017Q1	us-gaap	Share Based Compensation ShareBasedCompensation	134000
CY2017Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1578000
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00	pure
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.250	pure
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0128	pure
CY2017Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	0
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2017Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	19600000	shares
CY2017Q1	clxt	Increase Decrease In Due To From Related Parties Current IncreaseDecreaseInDueToFromRelatedPartiesCurrent	490000
CY2017Q1	clxt	Unrealized Transaction Gains Losses On Related Party Activity UnrealizedTransactionGainsLossesOnRelatedPartyActivity	27000
CY2018Q1	dei	Amendment Flag AmendmentFlag	false
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	40000
CY2018Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-5961000
CY2018Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	0
CY2018Q1	us-gaap	Costs And Expenses CostsAndExpenses	4307000
CY2018Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2018Q1	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	49000
CY2018Q1	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.03	pure
CY2018Q1	us-gaap	Depreciation Depreciation	156000
CY2018Q1	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	1.00	pure
CY2018Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.16
CY2018Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P4Y3M19D
CY2018Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2018Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2018Q1	dei	Document Type DocumentType	10-Q
CY2018Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2018Q1	us-gaap	Description Of Defined Contribution Pension And Other Postretirement Plans DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans	The Company provides a 401(k) defined contribution plan (the Plan) for participation by all regular fulltime employees who have completed three months of service
CY2018Q1	dei	Document Period End Date DocumentPeriodEndDate	2018-03-31
CY2018Q1	dei	Entity Registrant Name EntityRegistrantName	CALYXT, INC.
CY2018Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Net FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersNet	0
CY2018Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001705843
CY2018Q1	dei	Entity Incorporation State Country Name EntityIncorporationStateCountryName	Delaware
CY2018Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2018Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-6000
CY2018Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	123000
CY2018Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4370000
CY2018Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-11000
CY2018Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-456000
CY2018Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	25000
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-581000
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	880000
CY2018Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	Segment
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	645000
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-4370000
CY2018Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	Segment
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4296000
CY2018Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-68000
CY2018Q1	us-gaap	Interest Paid InterestPaid	124000
CY2018Q1	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	7000000
CY2018Q1	us-gaap	Nature Of Operations NatureOfOperations	<div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="break-inside: avoid"> <td valign="top" width="4%" align="left"><b>1.</b></td> <td valign="top" align="left"><b>Nature of Business</b></td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-variant-ligatures: normal; font-variant-caps: normal"> Calyxt, Inc., formerly known as Cellectis Plant Sciences, Inc., was founded in 2010 and incorporated in Delaware. The Company is headquartered in New Brighton, Minnesota. The Company is a consumer-centric, food- and agriculture-focused company. Prior to the Company’s initial public offering (IPO) on July 25, 2017, Calyxt was a wholly owned subsidiary of Cellectis. As of March 31, 2018, Cellectis owned approximately 79.1% of the Company’s outstanding common stock. Calyxt’s common stock is listed on the Nasdaq market under the ticker symbol “CLXT”.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-variant-ligatures: normal; font-variant-caps: normal"> The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form <font style="WHITE-SPACE: nowrap">10-Q</font> and Article 10 of Regulation <font style="WHITE-SPACE: nowrap">S-X.</font>Accordingly, they do not include all of the information and related notes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included in the accompanying financial statements. The results of operations for the period ended March 31, 2018 are not necessarily indicative of the results that may be expected for the full year.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-variant-ligatures: normal; font-variant-caps: normal"> This interim information should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form <font style="WHITE-SPACE: nowrap">10-K</font> for the year ended December 31, 2017, which was filed with the SEC on March 14, 2018 (the Annual Report).</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-variant-ligatures: normal; font-variant-caps: normal"> <b><i>Initial Public Offering</i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-variant-ligatures: normal; font-variant-caps: normal"> On July 25, 2017, the Company completed an IPO of its common stock. The Company sold an aggregate of 8,050,000 shares of common stock at a price of $8.00 per share, including 1,050,000 shares of common stock pursuant to the exercise of the underwriters’ option to purchase additional shares. In the aggregate, the Company received net proceeds from the IPO and exercise of the overallotment option of approximately $58.0 million, after deducting underwriting discounts and commissions of $3.1 million and offering expenses totaling approximately $3.3 million. As part of the IPO, Cellectis purchased 2,500,000 shares of common stock for a value of $20.0 million, the proceeds of which are included in the net proceeds of approximately $58.0 million. The Company used $5.7 million of the proceeds from Cellectis to pay a portion of the outstanding obligations owed to Cellectis.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-variant-ligatures: normal; font-variant-caps: normal"> <b><i>Stock Splits</i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-variant-ligatures: normal; font-variant-caps: normal"> On June 14, 2017, pursuant to the authorization provided in a written consent in lieu of a special meeting of the Company, the Company effected a stock split of the Company’s common stock at a ratio of <font style="WHITE-SPACE: nowrap"><font style="WHITE-SPACE: nowrap">100-for-1</font></font> and increased the number of shares of common stock authorized for issuance to 30,000,000 by filing a Certificate of Amendment with the Secretary of State of the State of Delaware.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-variant-ligatures: normal; font-variant-caps: normal"> On July 25, 2017, the Company amended its Amended and Restated Certificate of Incorporation to increase the authorized capital stock of the Company to 325,000,000 shares of which 275,000,000 shares are designated common stock, par value $0.0001, and 50,000,000 shares are designated preferred stock, par value $0.0001.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-variant-ligatures: normal; font-variant-caps: normal"> On July 25, 2017, concurrently with the closing of the IPO, the Company effected a stock split of the Company’s common stock at a ratio of <font style="WHITE-SPACE: nowrap"><font style="WHITE-SPACE: nowrap">2.45-for-1.</font></font> As a result of the stock split, each share of issued and outstanding common stock was converted into 2.45 shares of issued and outstanding common stock without changing the par value per share.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-variant-ligatures: normal; font-variant-caps: normal"> Since the par value of the common stock remained at $0.0001 per share subsequent to each stock split, the value of common stock recorded to the Company’s balance sheets has been retroactively increased to reflect the par value of the increased number of outstanding shares, with a corresponding decrease to additional <font style="WHITE-SPACE: nowrap">paid-in</font> capital. All share and per share data for periods occurring prior to the stock split that are included in the financial statements and related notes have been retroactively restated to reflect the stock splits.</p> </div>
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-41000
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-6565000
CY2018Q1	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	77000
CY2018Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	41000
CY2018Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	69000
CY2018Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	714000
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1093000
CY2018Q1	us-gaap	Sale Leaseback Transaction Date SaleLeasebackTransactionDate	2017-09-06
CY2018Q1	us-gaap	Sale Leaseback Transaction Annual Rental Payments SaleLeasebackTransactionAnnualRentalPayments	1400000
CY2018Q1	us-gaap	Sale Leaseback Transaction Imputed Interest Rate SaleLeasebackTransactionImputedInterestRate	0.08	pure
CY2018Q1	us-gaap	Sales Revenue Net SalesRevenueNet	11000
CY2018Q1	us-gaap	Sale Leaseback Transaction Rent Expense SaleLeasebackTransactionRentExpense	490000
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	40000
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.537	pure
CY2018Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y7M6D
CY2018Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.77
CY2018Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3214000
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00	pure
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.409	pure
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0245	pure
CY2018Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y10M25D
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	147000	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.39
CY2018Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	13.29
CY2018Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	10.39
CY2018Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	475000000
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0272	pure
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3260000
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	79875	shares
CY2018Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	196801	shares
CY2018Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	714000
CY2018Q1	dei	Trading Symbol TradingSymbol	CLXT
CY2018Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	27851162	shares
CY2018Q1	us-gaap	Use Of Estimates UseOfEstimates	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-variant-ligatures: normal; font-variant-caps: normal"> <b>Use of Estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: "Times New Roman"; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-variant-ligatures: normal; font-variant-caps: normal"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, the Company evaluates its estimates, including those related to stock-based compensation and the valuation allowance for deferred tax assets and derivatives. The Company bases its estimates on historical experience and on various other market-specific and relevant assumptions that it believes to be reasonable under the circumstances. Actual results could differ from those estimates.</p> </div>
CY2018Q1	clxt	Stock Issuance Costs Incurred During Noncash Or Partial Noncash Transaction StockIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	417000
CY2018Q1	clxt	Operating Leases Expiration Date OperatingLeasesExpirationDate	2018-05
CY2018Q1	clxt	Increase Decrease In Due To From Related Parties Current IncreaseDecreaseInDueToFromRelatedPartiesCurrent	-496000
CY2018Q1	clxt	Defined Contribution Plan Additional Matching Contribution Percent Of Match DefinedContributionPlanAdditionalMatchingContributionPercentOfMatch	0.50	pure
CY2018Q1	clxt	Property And Equipment Included In Financing Lease Obligation PropertyAndEquipmentIncludedInFinancingLeaseObligation	4529000
CY2018Q1	clxt	Unrealized Transaction Gains Losses On Related Party Activity UnrealizedTransactionGainsLossesOnRelatedPartyActivity	-8000

Files In Submission

Name	View Source	Status
0001193125-18-154661-index-headers.html	Edgar Link	pending
0001193125-18-154661-index.html	Edgar Link	pending
0001193125-18-154661.txt	Edgar Link	pending
0001193125-18-154661-xbrl.zip	Edgar Link	pending
clxt-20180331.xml	Edgar Link	completed
clxt-20180331.xsd	Edgar Link	pending
clxt-20180331_cal.xml	Edgar Link	unprocessable
clxt-20180331_def.xml	Edgar Link	unprocessable
clxt-20180331_lab.xml	Edgar Link	unprocessable
clxt-20180331_pre.xml	Edgar Link	unprocessable
d532634d10q.htm	Edgar Link	pending
d532634dex101.htm	Edgar Link	pending
d532634dex311.htm	Edgar Link	pending
d532634dex312.htm	Edgar Link	pending
d532634dex32.htm	Edgar Link	pending
d532634dex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CBUS
Cibus, Inc. Stock $cbus

2018 Q2 Form 10-Q Financial Statement

#000119312518154661 Filed on May 07, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBUS Cibus, Inc. Stock $cbus

2018 Q2 Form 10-Q Financial Statement

#000119312518154661 Filed on May 07, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBUS
Cibus, Inc. Stock $cbus